Back to BIIB

BIOGEN INC. Operating Cash Flow 2007-2026 | BIIB

Beta

What is operating cash flow?

Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.

What is BIOGEN INC.'s current operating cash flow?

BIOGEN INC. (BIIB) annual operating cash flow for 2025 was $2.20B, a 23.33% decline from 2024. BIOGEN INC. operating cash flow for the quarter ending March 31, 2026 was $645.5M.

What was BIOGEN INC.'s operating cash flow in 2024?

BIOGEN INC. annual operating cash flow for 2024 was $2.88B, a 85.85% increase from 2023.

What was BIOGEN INC.'s operating cash flow in 2023?

BIOGEN INC. annual operating cash flow for 2023 was $1.55B, a 11.77% increase from 2022.

What is BIOGEN INC.'s 5-year operating cash flow CAGR?

BIOGEN INC. operating cash flow grew at a compound annual growth rate (CAGR) of 12.22% from FY2020 to FY2025, going from $4.23B to $2.20B over 5 years.

Operating Cash Flow History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR-12.2%
FY2020
$4.23B
→
FY2025
$2.20B
07080910111213141516171819202122232425
5 years selected
Operating Cash Flow History
PeriodValueChangeSource
FY2025$2.20B-23.3%10-K
FY2024$2.88B+85.9%10-K
FY2023$1.55B+11.8%10-K
FY2022$1.38B-62.0%10-K
FY2021$3.64B-13.9%10-K
FY2020$4.23B-40.2%10-K
FY2019$7.08B+14.4%10-K
FY2018$6.19B+36.0%10-K
FY2017$4.55B-0.8%10-K
FY2016$4.59B+17.0%10-K
FY2015$3.92B+33.2%10-K
FY2014$2.94B+25.5%10-K
FY2013$2.35B+24.7%10-K
FY2012$1.88B+8.8%10-K
FY2011$1.73B+6.3%10-K
FY2010$1.62B+51.1%10-K
FY2009$1.07B-31.2%10-K
FY2008$1.56B+53.4%10-K
FY2007$1.02B-10-K
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →